Antifungal Immunity and its Mechanisms in Relation to Female Genitals;Protihoubová Imunita a Její Mechanismy ve Vztahu k Ženskému Genitálu

Ceska Gynekologie

Volumn 69, Issue 2, 2004, Pages 133-140

  Špaček, Jiří ^a   Jilek P ^b   Buchta, V ^a,b   Drahosova M ^a   Kalousek, I ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Fungal infections; Immunity; Vulvovaginal candidiasis

Indexed keywords

DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EXPERIENCE; FEMALE; FUNGAL STRAIN; HEALTH SURVEY; HUMAN; IMMUNE RESPONSE; IMMUNITY; MEDICAL LITERATURE; MYCOSIS; NONHUMAN; REVIEW; UNIVERSITY; VAGINA CANDIDIASIS; YEAST;

CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; IMMUNITY, MUCOSAL; RECURRENCE; VAGINA;

EID: 1942508093     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Ashman, R. B.: Candida albicans: pathogenesis, immunity and host defence. Res. Immunol., 149, 1998, s. 281-288.
2. Beck-Sagué, C. M., Narcis, W. R.: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis., 167, 1993, s. 1247-1251.
3. Berg, A. O., Heidrich, F. E., Fihn, S. D., et al.: Establishing the cause of genitourinary symptoms in women in a family practice. JAMA, 251, 1984, s. 620-625.
4. Bistoni, F., Cenci, E., Mancacci, A., et al.: Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J. Infect. Dis., 168, 1993, s. 1449-1457.
5. Blanchard, D. K., Michelini-Norris, M. B., Djeu, J. Y.: Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. Blood, 77, 1991, s. 2259-2265.
6. Bohler, K., Klade, H., Poitschek, C., et al.: Immunohistochemical study of in vivo and in vitro IgA coating of Candida species in vulvovaginal candidiasis. Genitour. Med., 70, 1994, s. 182-186.
7. Casadevall, A.: Antibody immunity and invasive fungal infections. Infest. Immunol., 63, 1995, s. 4211-4218.
8. Cassone, A., Boccanera, M., Adriani, D., et al.: Rats clearing a vaginal infection by Candida albicans acquire specific antibody-mediated resistance to vaginal reinfection. Infect. Immunol., 63, 1995, s. 2619-2625.
9. Cutler, J. E.: The Candida albicans phosphomannan komplex in Candida-host interactions. Res. Immunol., 149, 1998, s. 299-308.
10. Domer, J. E., Lehrer, R. J.: Introduction to Candida: systemic candidiasis. In: Murphy, J. W., Friedman, H., Bendinelli, M., eds. Fungal infections and immune response. New York: Plenum Press, 1993, s. 49-116.
11. Fader, R. C., Nunez, D., Unbehagen, J., et al.: Experimental candidiasis after thermal injury. Infect. Immunol., 49, 1985, s. 780-784.
12. Fidel, P. L. Jr.: Immunity to Candida. Oral Diseases, 8, Suppl., 2, 2002, s. 69-75.
13. Fidel, P. L. Jr., Sobel, J. D.: Protective immunity in experimental Candida vaginitis. Res. Immunol., 149, 1998, s. 361-373.
14. Fidel, P. L. Jr., Lynch, M. E., Redondo-Lopez, V., et al.: Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J. Infect. Dis., 168, 1993, s. 1458-1465.
15. Fidel, P. L., Sobel, J. D.: Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin. Microbiol. Rev., 9, 1996, s. 335-348.
16. Fong, I. W., McCleary, P., Read, S.: Cellular immunity in patients with recurrent or refractory vulvovaginal moniliasis. Am. J. Obstet. Gynecol., 166, 1992, s. 887-890.
17. Harrison, T., Levitz, S. M.: Immunology. In Anaissie, E. J., Ginnis, M. R., Pfaller, M. A.: Clinical Mycology, Churchill Livingstone, 2003.
18. Hobbs, Jr., Briden, D., Davidson, F., et al.: Immunological aspects of candidal vaginitis. Proc. R. Soc. Med., 70, 1977, s. 11-14.
19. Hurley, R.: Recurrent Candida infection. Clin. Obstet. Gynecol., 8, 1981, s. 209-213.
20. Jílek, P.: Základy imunologie. Anyway, Praha, 2002.
21. Jílek, P., Špaček, J., Kučera, Z., et al.: Imunologický profil zen s rekurentní vulvovaginální kandidózou (RVVK). 17. sjezd českých a slovenských alergologů a klinických imunologů. Liberec, 25.-28.10.2000, Abstraktum: Alergie roč. 2, Suppl. 2, s. 17.
22. 2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect. Immunol., 58, 1990, s. 260-262.
23. Kent, H. L.: Epidemiology of vaginitis. Am. J. Obstet. Gynecol., 165, 1991, s. 1168-1176.
24. Klein, R. S., Harris, C. A., Small, C. B., et al.: Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med., 311, 1984, s. 354-358.
25. Kozel, T. R.: Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev., 9, 1996, s. 34-46.
26. Kutteh, W. H., Moldoveanu, Z., Mestecky, J.: Mucosal immunity in the female reproductive tract: Correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res. Hum. Retrovit., 14, (Suppl. 1, 1998, s. 51-55.
27. Law, E. J., Lee, K. L., Tesari, R. P.: Enhanced susceptibility of burned mice to experimental infection with Candida albicans. Mykosen, 27, 1984, s. 562-572.
28. Leigh, J. E., Barousse, M., Swoboda, R. K., et al.: Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis. J. Infect. Dis., 183, 2001, s. 277-285.
29. Levitz, S. M.: Overview of host defenses in fungal infections. Clin. Infect. Dis., 14, (Suppl. 1), 1992, s. 37-42.
30. Levitz, S. M., North, E. A.: Gamma interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans. Infect. Immunol., 64, 1996, s. 1595-1599.
31. Li, S. P., Lee, S., Domer, J.: Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphotyl lipid A. Infect. Immunol., 66, 1998, s. 1392-1399.
32. Magliani, W., Conti, S., Cassone, A., et al.: New immunotherapeutic strategies to control vaginal candidiasis. Trends Mol. Med., 8, 2002, s. 121-126.
33. Mathur, S., Virella, G., Koistinen, J., et al.: Humoral immunity in vaginal candidiasis. Infect Immunol., 15, 1977, s. 287-294.
34. Mendling, W., Koldovsky, U.: Immunological investigations in vaginal mycoses. Mycoses, 39, 1996, s. 177-183.
35. Mestecky, J., Russell, M. W.: Induction of mucosal immune responses in the human genital tract. FEMS Immunol. Med. Microbiol., 27, 2000, s. 351-355.
36. Murphy, J. W.: Cell-mediated imunity and medically releated fungi. In: Effects of microbes on the immune system, Cunningham, M. W., Fujinami, R. S. (eds.). Philadelphia: Lippincot Williams and Wilkins, 2000.
37. Nawrot, U., Grzybek-Hryncewicz, K., Zielska, U., et al.: The study of cell-mediated immune response in recurrent vulvovaginal candidiasis. FEMS Immunol. Med. Microbiol., 29, 2000, s. 89-94.
38. Odds, F. C.: Candida and candidosis. Leicester, England: Leicester University Press, 1979, s. 205-307.
39. Odds, F. C.: Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects. Internat. J. Antimicrob. Agents, 6, 1996, s. 141-144.
40. Ollert, M. W., Wadsworth, E., Calderone, R. A.: Reduced expression of the functionally active complement receptor for C3b but not for C3d on an avirulent mutant of Candida albicans. Infect. Immunol., 58, 1990, s. 909-913.
41. Parr, M. B., Parr, E. L.: Antigen recognition in the female reproductive tract. I. Uptake of intraluminal protein tracers in the mouse vagina. J. Reprod. Immunol., 17, 1990, s. 101-114.
42. Parr, M. B., Parr, E. L.: Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol. Reprod., 44, 1991, s. 491-498.
43. Parr, M. B., Parr, E. L.: Mucosal immunity in the female and male reproductive tracts. In: Ogra, P. L., Mestecky, J. J., Lamm, M. E., (eds.): Handbook of mucosal immunity. San Diego, Calif.: Academic Press, s. 677-689.
44. Regulez, et al.: Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis. Gynecol. Obstet. Invest., 37, 1994, s. 110-114.
45. Rigg, D., Miller, M. M., Metzger, W. J.: Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy. Am. J. Obstet. Gynecol., 162, 1990, s. 332-336.
46. Romani, L., Bistoni, F., Puccetti, P.: Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol., 10, 2002, s. 508-514.
47. Rosedale, N., Browne, M. B.: Hyposensitisation in the management of recurring vaginal candidiasis. Ann. Allergy, 43, 1979, s. 250-253.
48. Schuman, P., Sobel, J. D., Ohmit, S., et al.: Mucosal Candida colonization and candidiasis in women with or without at-risk for HIV infection. Clin. Infect. Dis., 27, 1998, s. 1161-1167.
49. Sobel, J. D.: Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol., 152, 1985, s. 924-935.
50. Sobel, J. D.: Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. NY, Acad. Sci., 544, 1988, s. 547-557.
51. Stoney, V. C., Hurley, R.: Candida precipitins in pregnant women: validity of the test systems used. J. Clin. Pathol., 27, 1974, s. 66-69.
52. Syversson, R. A., Buckley, H., Gibian, J., et al.: Cellular and humoral immune status in women with chronic Candida vaginitis. Am. J. Obstet. Gynecol., 134, 1979, s. 624-627.
53. Špaček, J., Buchta, V., Jílek, P.: Klinické pozorování u pacientek s rekurentní vulvovaginá lní kandidózou. Gynekolog, 9, 2000, s. 274-280.
54. Špaček, J., Buchta, V., Krejsek, J., et al.: Depo-Provera in the treatment of chronic vulvovaginal candidiasis. 5th World Congress for Infectious Diseases in Obstetric and Gynaecology, 1-8th of November 1997. Cape Town, South Africa. Book of abstracts, s. 47.
55. Vasquez-Torres, A., Balish, E.: Macrophages in resistance to candidiasis. Microbiol. Mol. Biol. Rev., 61, 1997, s. 170-192.
56. Waldman, R. H., Cruz, J. M., Rowe, D. S.: Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions. Clin. Exp. Immunol., 10, 1972, s. 227-234.
57. Wang, Y., Li, S. P., Moser, S. A., et al.: Cytokine involvement in immunomodulatory activity affected by mannan. Infect. Immunol., 66, 1998, s. 1384-1391.
58. Wira, C. R., Richardson, J., Prabhala, R.: Endocrine regulation of mucosal immunity: effect of sex hormones and cytokines on the afferent and efferent arms of the immune system in the female reproductive tract. In: Ogra, P. L., Mestecky, J. J., Lamm, M. E. (eds.): Handbook of mucosal immunity. 1994, San Diego: Academic Press, s. 705-718.
59. Wira, C. R., Stern, J. E.: Endocrine regulation of the mucosal immune system in the female reproductive tract: Control of IgA, IgG, and secretory component during the reproductive cycle, at implantation, and throughout pregnancy. In: Rasqualini, J. R., Scholler, R. (eds.): Hormones and fetal pathophysiology. New York: Marcel Dekker, 1992, s. 343-367.
60. Witkin, S. S.: Immunologic factors influencing susceptibility to recurrent candidal vaginitis. Clin. Obstet. Gynecol., 34, 1991, s. 662-668.
61. Witkin, S. S., Jeremias, J., Ledger, W. J.: A localized vaginal allergic response in women with recurrent vaginitis. J. Allergy Clin. Immunol., 81, 1988, s. 412-416.
62. Witkin, S. S., Jeremias, J., Ledger, W. J.: Vaginal eosinophils and IgE to Candida albicans in women with recurrent vaginitis. J. Med. Vet. Mycol., 27, 1989, s. 57-58.
63. Witkin, S. S., Hirsch, J., Ledger, W. J.: A macrophage defect in women recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am. J. Obstet. Gynecol., 155, 1986, s. 790-795.
64. Witkin, S. S., Yu, I. R., Ledger, W. J.: Inhibition of Candida albicans-induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am. J. Obstet. Gynecol., 147, 1983, s. 809-811.
65. 2 production by peripheral blood mononuclear cells from healthy women and women with recurrent candidal vaginitis. J. Infect. Dis., 164, 1991, s. 396-399.
66. Živný, J., Šterzl, J.: Specifická slizniční imunita ženského reprodukční ho traktu: obecný úvod (část 1). Čes. Gynek., 68, 2003, s. 206-209.